THE ITALFARMACY WORLD

EXPERIENCE

From experience comes our best insights

The history of Italfarmacia kicked off in 1995 with a specific goal: to develop and manufacture innovative products capable of ensuring, in addition to proven efficacy, original formulations to meet different needs in the health and wellness area. The project is ambitious, but the company’s founder, Mario Marchetti, can draw on his extensive experience in the drug.

CULTURE

Looking at things from above to see farther

The innate inclination toward research and the many experiences gained in the pharmaceutical field have been the dominant factor for Italfarmacia from the beginning, which, thanks to its ability to take a broad view of the world of health, has been able to grasp the still unmet wellness demands in advance. The ability of Italfarmacia’s management was and is therefore to be able to translate these signals into concrete stimuli to investigate and, where possible, find the most appropriate solutions through the development of products that meet the various needs.

INTUITION

Anticipating market needs interests us as much as meeting them

Intuiting and catching in advance every signal coming from the changed health needs and new realities of care to be offered to the physician, and consequently to its Partners, is the priority in all Italfarmacia’s development programs. Combining knowledge already acquired, but applying it in entirely new ways, to the point of arriving at new original, effective, and well-tolerated therapies is the challenge to achieve the most prestigious goals, inescapable with worldwide patent recognition.

RELIABILITY

Translating our expertise into lasting relationships of trust

Doing wide-ranging research with commitment, rigor, knowledge of the subject matter, and being able to concretize study hypotheses through the realization of useful and safety-guaranteed products has been the key to Italfarmacia’s success from the very beginning. Major pharmaceutical companies, interested in the many therapeutic options gradually developed by Italfarmacia, have entered into collaborations through exclusive licensing agreements in countries of specific interest.

CONNECTION

We like to create deep and lasting relationships with all our stakeholders

In the numerous collaborations that have gradually developed in each phase of the life of its products, from the ideation phase to the industrial phase aimed at “contract” production, Italfarmacia’s ability has been to succeed in coordinating different activities without ever losing sight of objectives and timeframes. In its research programs, it has never neglected to investigate the main end-points, the verification and realization of which represent the sure success in obtaining an international patent; at the same time, it has always maintained the utmost attention on the final goals set: to fill market shortcomings, to meet the expectations of increasingly demanding patients, to pander to specific needs of companies by ensuring that their preparations are suitable to be quickly commercialized.

EXPERIENCE

The history of Italfarmacia kicked off in 1995 with a specific goal: to develop and manufacture innovative products capable of ensuring, in addition to proven efficacy, original formulations to meet different needs in the health and wellness area. The project is ambitious, but the company’s founder, Mario Marchetti, can draw on his extensive experience in the drug. These skills will soon enable Italfarmacia to differentiate itself and compete in an increasingly articulated, crowded, globalized scenario, playing an active role in the identification and treatment of diseases with high social impact. Italfarmacia, from the very first months of its existence, has won the trust of its stakeholders, business partners, doctors, directly patients. This continuous attention to market trends and changing health needs has always guided the company’s research programs to identify and produce modern preparations in line with the ever-increasing expectations of well-being. Many of the activities carried out have received official recognition, such as international patents, proving the absolute originality of the ideas and products. Case in point is Amin 21K®, an amino acid treatment for the treatment of obesity, overweight, and localized adiposity. Italfarmacia in carrying out its research and development plans has constantly related with prestigious University Institutes, Hospitals, national and/or international R&D laboratories, among those able to offer the best scientific expertise in relation to the specifics of the company’s programs. With them Italfarmacia has initiated collaboration contracts, many of which are still in place, realizing useful synergies to finalize the different scientific plans into industrial scaleup programs.

CULTURE

Looking at things from above to see farther

The innate inclination toward research and the many experiences gained in the pharmaceutical field have been the dominant factor for Italfarmacia from the beginning, which, thanks to its ability to take a broad view of the world of health, has been able to grasp the still unmet wellness demands in advance. The ability of Italfarmacia’s management was and is therefore to be able to translate these signals into concrete stimuli to investigate and, where possible, find the most appropriate solutions through the development of products that meet the various needs.

INTUITION

Anticipating market needs interests us as much as meeting them

Intuiting and catching in advance every signal coming from the changed health needs and new realities of care to be offered to the physician, and consequently to its Partners, is the priority in all Italfarmacia’s development programs. Combining knowledge already acquired, but applying it in entirely new ways, to the point of arriving at new original, effective, and well-tolerated therapies is the challenge to achieve the most prestigious goals, inescapable with worldwide patent recognition.

RELIABILITY

Translating our expertise into lasting relationships of trust

Doing wide-ranging research with commitment, rigor, knowledge of the subject matter and being able to concretize study hypotheses through the realization of useful and guaranteed products from a safety point of view has been the key to Italfarmacia’s success since its first steps. Important pharmaceutical companies, interested in the numerous therapeutic options gradually developed by Italfarmacia, entered into collaborations through exclusive licensing agreements in the countries of specific interest. In this way, interference and/or overlapping in commercial activities in the different countries was avoided, with total respect for the presence and needs of each individual company.The second and equally important reliability factor should be traced to the safety of use of the preparations developed: products that are effective, well tolerated and free from side effects. This safety is ensured by strict adherence to the guidelines dictated by GLP and GMP standards, which are particularly useful when developing and producing biopolymers, biotechnological substances processed by fermentation methods, which is precisely what hyaluronic acid is.Such a global commitment takes on even more value today in an increasingly globalized world grappling with problems of counterfeiting and illegal sales of health products for human use. For Italfarmacia, on the other hand, it is imperative to be able to be recognized as always reliable, so as not to disappoint the expectations of those who believe in its capabilities and the rigor of its working methods.

CONNECTION

We like to create deep and lasting relationships with all our stakeholders

In the numerous collaborations that have gradually developed in each phase of the life of its products, from the ideation phase to the industrial phase aimed at “contract” production, Italfarmacia’s ability has been to succeed in coordinating different activities without ever losing sight of objectives and timeframes. In its research programs, it has never neglected to investigate the main end-points, the verification and realization of which represent the sure success in obtaining an international patent; at the same time, it has always maintained the utmost attention on the final goals set: to fill market shortcomings, to meet the expectations of increasingly demanding patients, to pander to specific needs of companies by ensuring that their preparations are suitable to be quickly commercialized. Coordination of so many and so diverse activities is even more complex by having to respect for each phase the time factor, which is crucial for the patent process, for the answers to be given to the markets, and more so not to disappoint companies’ expectations. Another prerogative, punctuality, has certainly contributed to Italfarmacia’s success. To understand the efforts, but also the great capabilities of Italfarmacia in governing so many different paths, it is enough to reflect on the actions to be taken to achieve an international patent. The guidelines differ from continent to continent, from country to country, the technical updates required by the relevant agencies differ in content, in bureaucratic details, and in reporting times. In short, an amount of data to be monitored for each patent application, which would risk blowing up any business program if Italfarmacia did not bring to bear all its many years of expertise/ability to connect the different activities with precise work programs that interface with each other. With its success to date, Italfarmacia continues to prove that it lives up to its mission: to never stop observing and learning in order to improve its innovative vision.

EXPERIENCE

The history of Italfarmacia kicked off in 1995 with a specific goal: to develop and manufacture innovative products capable of ensuring, in addition to proven efficacy, original formulations to meet different needs in the health and wellness area. The project is ambitious, but the company’s founder, Mario Marchetti, can draw on his extensive experience in the drug. These skills will soon enable Italfarmacia to differentiate itself and compete in an increasingly articulated, crowded, globalized scenario, playing an active role in the identification and treatment of diseases with high social impact. Italfarmacia, from the very first months of its existence, has won the trust of its stakeholders, business partners, doctors, directly patients. This continuous attention to market trends and changing health needs has always guided the company’s research programs to identify and produce modern preparations in line with the ever-increasing expectations of well-being. Many of the activities carried out have received official recognition, such as international patents, proving the absolute originality of the ideas and products. Case in point is Amin 21K®, an amino acid treatment for the treatment of obesity, overweight, and localized adiposity. Italfarmacia in carrying out its research and development plans has constantly related with prestigious University Institutes, Hospitals, national and/or international R&D laboratories, among those able to offer the best scientific expertise in relation to the specifics of the company’s programs. With them Italfarmacia has initiated collaboration contracts, many of which are still in place, realizing useful synergies to finalize the different scientific plans into industrial scaleup programs.

CULTURE

Looking at things from above to see farther

The innate inclination toward research and the many experiences gained in the pharmaceutical field have been the dominant factor for Italfarmacia from the beginning, which, thanks to its ability to take a broad view of the world of health, has been able to grasp the still unmet wellness demands in advance. The ability of Italfarmacia’s management was and is therefore to be able to translate these signals into concrete stimuli to investigate and, where possible, find the most appropriate solutions through the development of products that meet the various needs.

INTUITION

Anticipating market needs interests us as much as meeting them

Intuiting and catching in advance every signal coming from the changed health needs and new realities of care to be offered to the physician, and consequently to its Partners, is the priority in all Italfarmacia’s development programs. Combining knowledge already acquired, but applying it in entirely new ways, to the point of arriving at new original, effective, and well-tolerated therapies is the challenge to achieve the most prestigious goals, inescapable with worldwide patent recognition.

RELIABILITY

Translating our expertise into lasting relationships of trust

Doing wide-ranging research with commitment, rigor, knowledge of the subject matter and being able to concretize study hypotheses through the realization of useful and guaranteed products from a safety point of view has been the key to Italfarmacia’s success since its first steps. Important pharmaceutical companies, interested in the numerous therapeutic options gradually developed by Italfarmacia, entered into collaborations through exclusive licensing agreements in the countries of specific interest. In this way, interference and/or overlapping in commercial activities in the different countries was avoided, with total respect for the presence and needs of each individual company.The second and equally important reliability factor should be traced to the safety of use of the preparations developed: products that are effective, well tolerated and free from side effects. This safety is ensured by strict adherence to the guidelines dictated by GLP and GMP standards, which are particularly useful when developing and producing biopolymers, biotechnological substances processed by fermentation methods, which is precisely what hyaluronic acid is.Such a global commitment takes on even more value today in an increasingly globalized world grappling with problems of counterfeiting and illegal sales of health products for human use. For Italfarmacia, on the other hand, it is imperative to be able to be recognized as always reliable, so as not to disappoint the expectations of those who believe in its capabilities and the rigor of its working methods.

CONNECTION

We like to create deep and lasting relationships with all our stakeholders

In the numerous collaborations that have gradually developed in each phase of the life of its products, from the ideation phase to the industrial phase aimed at “contract” production, Italfarmacia’s ability has been to succeed in coordinating different activities without ever losing sight of objectives and timeframes. In its research programs, it has never neglected to investigate the main end-points, the verification and realization of which represent the sure success in obtaining an international patent; at the same time, it has always maintained the utmost attention on the final goals set: to fill market shortcomings, to meet the expectations of increasingly demanding patients, to pander to specific needs of companies by ensuring that their preparations are suitable to be quickly commercialized. Coordination of so many and so diverse activities is even more complex by having to respect for each phase the time factor, which is crucial for the patent process, for the answers to be given to the markets, and more so not to disappoint companies’ expectations. Another prerogative, punctuality, has certainly contributed to Italfarmacia’s success. To understand the efforts, but also the great capabilities of Italfarmacia in governing so many different paths, it is enough to reflect on the actions to be taken to achieve an international patent. The guidelines differ from continent to continent, from country to country, the technical updates required by the relevant agencies differ in content, in bureaucratic details, and in reporting times. In short, an amount of data to be monitored for each patent application, which would risk blowing up any business program if Italfarmacia did not bring to bear all its many years of expertise/ability to connect the different activities with precise work programs that interface with each other. With its success to date, Italfarmacia continues to prove that it lives up to its mission: to never stop observing and learning in order to improve its innovative vision.